Avicanna Inc. (TSX: AVCN)
Canada
· Delayed Price · Currency is CAD 0.350
-0.050 (-12.50%)
Jul 2, 2024, 3:55 PM EDT
Avicanna Revenue
Avicanna had revenue of 22.07M CAD in the twelve months ending March 31, 2024, with 427.90% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 6.45M CAD with 450.81% year-over-year growth. In the year 2023, Avicanna had annual revenue of 16.79M CAD with 314.82% growth.
Revenue (ttm)
22.07M
Revenue Growth
+427.90%
P/S Ratio
1.55
Revenue / Employee
253,643
Employees
87
Market Cap
34.27M CAD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 16.79M | 12.74M | 314.82% |
| Dec 31, 2022 | 4.05M | 778.98K | 23.83% |
| Dec 31, 2021 | 3.27M | 1.70M | 108.20% |
| Dec 31, 2020 | 1.57M | 1.40M | 833.16% |
| Dec 31, 2019 | 168.25K | 50.28K | 42.62% |
| Dec 31, 2018 | 117.97K | 91.31K | 342.49% |
| Dec 31, 2017 | 26.66K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb Corporation | 5.93B |
| Curaleaf Holdings, Inc. | 1.85B |
| Bausch Health Companies Inc. | 12.26B |
| Tilray Brands, Inc. | 1.02B |
| WELL Health Technologies Corp. | 838.19M |
| Sienna Senior Living Inc. | 824.26M |
| Canopy Growth Corporation | 329.61M |
| Extendicare Inc. | 1.35B |